✦ LIBER ✦

1058 A phase II evaluation of bone marrow protection by ethyol® (Amifostine)(Am) in patients with non-small cell lung cancer (NSCLC) treated with carboplatin(c)

✍ Scribed by Betticher, D.C.; Anderson, H.; Ranson, M.; Thatcher, N.; Habboubi, N.; Meely, K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Carboplatin combined with amifostine, a

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 144 KB

A phase III randomized study of carbopla

✍ Belani, C.P; Ansari, R.H; Atkins, J.N; Hon, J.K; Modiano, M.R; Budd, T.G 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 104 KB

55 - A phase III randomised study of car

✍ H. Anderson; V. Mercer; L. Russell; N. Habboubi; N. Thatcher 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 268 KB

3044 Mistletoe as complementary treatmen

✍ G. Bar-Sela; M. Wollner; A. Agbarya; L. Zwergel; I. Maykler; L. Sharvit; A. Kute 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Bone marrow-sparing and prevention of al

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 139 KB

P-522 A phase II trial of Alimta plus ca

✍ Zinner, Ralph G.; Obasaju, Coleman K.; Fossella, Frank V.; Pisters, Katherine M. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 152 KB